|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 14/82 | |
| A61K 39/00 | |||
| A61K 45/06 | |||
| A61K 31/7068 | |||
| A61K 35/17 |
| (11) | Patento numeris | 3140320 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15720986.7 |
| Europos patento paraiškos padavimo data | 2015-05-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-03-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-12-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2015/059861 |
| Data | 2015-05-05 |
| (87) | Numeris | WO 2015/169804 |
| Data | 2015-11-12 |
| (30) | Numeris | Data | Šalis |
| 14167265 | 2014-05-06 | EP |
| (72) |
ERIKSEN, Jon Amund, NO
GAUDERNACK, Gustav, NO
|
| (73) |
TARGOVAX ASA ,
Vollsveien 19, 1366 Lysaker,
NO
|
| (54) | PEPTIDE VACCINE COMPRISING MUTANT RAS PEPTIDE AND CHEMOTHERAPEUTIC AGENT |
| PEPTIDE VACCINE COMPRISING MUTANT RAS PEPTIDE AND CHEMOTHERAPEUTIC AGENT |